Protein Sciences wins FDA OK for egg-free Flublok
This article was originally published in Scrip
Executive Summary
Protein Sciences’ long road to get to US FDA approval of the firm's novel influenza vaccine, which does not rely on chicken eggs but an insect virus, finally paid off on 16 January – with the win coming in the midst of a bad flu season that has struck most states across the nation.